Overview
Srinivas Nanduri-Srinivas practices practicing medicine in Hyderabad, India.
His clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA).
He is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Srinivas Nanduri-Srinivas
Is Srinivas Nanduri-Srinivas a top-rated expert for Methicillin-Resistant Staphylococcus Aureus (MRSA)?
MediFind is an objective health platform that identifies experts based on real-world data. Srinivas Nanduri-Srinivas is classified as an Experienced expert for Methicillin-Resistant Staphylococcus Aureus (MRSA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Srinivas Nanduri-Srinivas participate in research or clinical trials?
Yes. Srinivas Nanduri-Srinivas has published 24 articles and abstracts on conditions like Methicillin-Resistant Staphylococcus Aureus (MRSA). You can view a list of Srinivas Nanduri-Srinivas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Methicillin-Resistant Staphylococcus Aureus (MRSA)Mr. Nanduri-Srinivas isExperienced. Learn about Methicillin-Resistant Staphylococcus Aureus (MRSA).